TY - JOUR
T1 - Guidelines for the management of cutaneous lymphomas (2011)
T2 - A consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group
AU - Sugaya, Makoto
AU - Hamada, Toshihisa
AU - Kawai, Kazuhiro
AU - Yonekura, Kentaro
AU - Ohtsuka, Mikio
AU - Shimauchi, Takatoshi
AU - Tokura, Yoshiki
AU - Nozaki, Koji
AU - Izutsu, Koji
AU - Suzuki, Ritsuro
AU - Setoyama, Mitsuru
AU - Nagatani, Tetsuo
AU - Koga, Hiroshi
AU - Tani, Mamori
AU - Iwatsuki, Keiji
PY - 2013/1
Y1 - 2013/1
N2 - In 2010, the first Japanese edition of guidelines for the management of cutaneous lymphoma was published jointly by the Japanese Dermatological Association (JDA) and the Japanese Skin Cancer Society (JSCS) - Lymphoma Study Group. Because the guidelines were revised in 2011 based on the most recent data, we summarized the revised guidelines in English for two reasons: (i) to inform overseas clinicians about our way of managing common types of cutaneous lymphomas such as mycosis fungoides/Sézary syndrome; and (ii) to introduce Japanese guidelines for lymphomas peculiar to Asia, such as adult T-cell leukemia/lymphoma and extranodal natural killer/T-cell lymphoma, nasal type. References that provide scientific evidence for these guidelines have been selected by the JSCS - Lymphoma Study Group. These guidelines, together with the degrees of recommendation, have been made in the context of limited medical treatment resources, and standard medical practice within the framework of the Japanese National Health Insurance system.
AB - In 2010, the first Japanese edition of guidelines for the management of cutaneous lymphoma was published jointly by the Japanese Dermatological Association (JDA) and the Japanese Skin Cancer Society (JSCS) - Lymphoma Study Group. Because the guidelines were revised in 2011 based on the most recent data, we summarized the revised guidelines in English for two reasons: (i) to inform overseas clinicians about our way of managing common types of cutaneous lymphomas such as mycosis fungoides/Sézary syndrome; and (ii) to introduce Japanese guidelines for lymphomas peculiar to Asia, such as adult T-cell leukemia/lymphoma and extranodal natural killer/T-cell lymphoma, nasal type. References that provide scientific evidence for these guidelines have been selected by the JSCS - Lymphoma Study Group. These guidelines, together with the degrees of recommendation, have been made in the context of limited medical treatment resources, and standard medical practice within the framework of the Japanese National Health Insurance system.
KW - Sézary syndrome
KW - adult T-cell leukemia/lymphoma
KW - cutaneous lymphoma
KW - guideline
KW - mycosis fungoides
UR - http://www.scopus.com/inward/record.url?scp=84872493827&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872493827&partnerID=8YFLogxK
U2 - 10.1111/j.1346-8138.2012.01639.x
DO - 10.1111/j.1346-8138.2012.01639.x
M3 - Review article
C2 - 22900999
AN - SCOPUS:84872493827
SN - 0385-2407
VL - 40
SP - 2
EP - 14
JO - Journal of Dermatology
JF - Journal of Dermatology
IS - 1
ER -